Gel-200 Extension and Open-Label Study in Osteoarthritis of the Knee

Completed · Phase 3

Conditions studied: Osteoarthritis of the Knee

In brief

The purpose of this study is to determine if a single or repeat intra-articular injection of Gel-200 is safe and effective in subjects with symptomatic osteoarthritis of the knee and to determine if original SI-6606/01 Gel-200 therapy is durable beyond the original study.

Key facts

Study ID

NCT00450112

Run by

Seikagaku Corporation

People needed

202

Starts

2007-03-01

Expected to finish

2009-06-01

Last updated by the study team

2011-08-22

Who can join

Age: 40 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Previous participation in study SI-6606/01.

You may not qualify if…

• Female subjects who are pregnant or lactating.

Where it is running

• SKK — Plantation, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.